A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
El desafío del cambio de la vacuna inactivada contra poliomielitis en América Latina: Declaración de la Sociedad Latinoamericana de Infectología Pediátrica (SLIPE)
2014
Revista chilena de infectología
Even though we have already covered 99% of the path to eradicate poliomyelitis from the world, this disease is still causing paralysis in children. Its eradication means not only the end of wild poliovirus circulation, but vaccine-derived poliovirus circulation as well. Taking into account different factors such as: current epidemiological data, adverse events of the attenuated oral poliomyelitis vaccine (OPV), the availability of an injectable inactivated vaccine (IPV) without the potential of
doi:10.4067/s0716-10182014000500012
pmid:25491459
fatcat:szkrsgyi2rdjfoxzcz4ckzkfa4